Aktuelle Kurse von TEVOGEN BIO HLDGS INC.

Börse	Ticker	Währung	Letzter Umsatz	Kurs	Tagesveränderung	Tagesveränderung %
NASDAQ	TVGN	USD	06.02.2025 10:44	1,45 USD	1,50 USD	-3,33 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-1,87 %	8,23 %	28,59 %	-12,68 %	233,64 %	-71,55 %	-84,53 %

Company Profile for TEVOGEN BIO HLDGS INC. Share

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Company Data

Name TEVOGEN BIO HLDGS INC.

Company Tevogen Bio Holdings Inc.

Symbol TVGN

Website https://tevogen.com

Primary Exchange

Frankfurt

WKN A402TW

ISIN US88165K1016

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.

Market Capitalization 245 Mio

Country United States of America

Currency EUR

Employees 0,0 T

Address 15 Independence Blvd, 07059 Warren

IPO Date 2022-01-05

ID Changes

Date	From	To
15.02.2024	LGST	TVGN

Ticker Symbols

Name	Symbol
Frankfurt	G28.F
NASDAQ	TVGN

More Shares

Investors who TEVOGEN BIO HLDGS INC. hold also have the following shares in their portfolio:

POWERCHIP TECHNOLOGY CORPORATION - GDS (EACH REPR 10 TWD10)(REG S) Depository Receipt

VINCI S.A. 19/34 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog